White label – Pompe disease - ClinicalTrials.eu

Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

Not recruiting

2 1
Investigated Drugs:
- Deucravacitinib
Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

Not recruiting

2 1 1 1
Investigated Diseases:
- Hepatorenal syndrome
- Acute kidney injury
Investigated Drugs:
- R2R01
- Terlipressin Acetate
Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients

Not recruiting

3 1 1
Investigated Diseases:
- Heart transplant
- Renal failure
Investigated Drugs:
- Dapagliflozin
Study on the Safety and Effects of Garadacimab for Preventing Hereditary Angioedema in Children Aged 2 to 11

Not recruiting

3 1 1
Investigated Diseases:
- Hereditary angioedema
Investigated Drugs:
- Garadacimab
Study on the Effect of Botulinum Toxin Type A and Sodium Chloride for Patients with Chronic Neuropathic Pain

Not recruiting

3 1 1
Investigated Diseases:
- Neuropathy peripheral
Investigated Drugs:
- Botulinum Toxin Type A
- Sodium Chloride
Study of Volrustomig for Patients with Advanced Solid Tumors with Mature Tertiary Lymphoid Structures

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Volrustomig
Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Not recruiting

3 1 1
Investigated Drugs:
- Adalimumab
- Upadacitinib
+5
Study on GnRH Agonists for Ovulation and Luteal Support in IVF Patients: Comparing GnRH Agonist with hCG and Progesterone

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Not recruiting

3 1 1
Investigated Drugs:
- Isis 696844
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies